HealthCare Global Enterprises Limited reported earnings results for the third quarter and nine months ended December 31, 2025. For the third quarter, the company reported sales was INR 6,311.8 million compared to INR 5,575.5 million a year ago. Revenue was INR 6,355.4 million compared to INR 5,632.1 million a year ago. Net loss was INR 94.3 million compared to net income of INR 69.8 million a year ago. Basic loss per share from continuing operations was INR 0.68 compared to basic earnings per share from continuing operations of INR 0.5 a year ago. Diluted loss per share from continuing operations was INR 0.68 compared to diluted earnings per share from continuing operations of INR 0.49 a year ago.
For the nine months, sales was INR 18,881.4 million compared to INR 16,347.1 million a year ago. Revenue was INR 19,050 million compared to INR 16,622.7 million a year ago. Net income was INR 115.9 million compared to INR 370.5 million a year ago. Basic earnings per share from continuing operations was INR 0.82 compared to INR 2.66 a year ago. Diluted earnings per share from continuing operations was INR 0.82 compared to INR 2.62 a year ago.
HealthCare Global Enterprises Limited is an India-based cancer care provider. The Company is a provider of specialty healthcare focused on cancer and fertility. The Company operates cancer care network in India in terms of the total number of private cancer treatment centers under the brand HCG. The Company also provide fertility treatment under its Milann brand. Its Milann fertility centers provide reproductive medicine services, including assisted reproduction, gynecological endoscopy and fertility preservation; and follow a multidisciplinary and technology focused approach to diagnosis and treatment. The Triesta brand, it offers oncology diagnostics, biomarker and translational research, and laboratory services. The Company also operates comprehensive cancer care center in Indore, Madhya Pradesh. The Company is also engaged in radiation business in Indore, Madhya Pradesh.
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
ESG MSCI
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
